返回
NovaBay Pharmaceuticals Inc（NBY）价格
NBY 股价走势图
NBY 收益
NovaBay Pharmaceuticals Inc
$14.77
16.39%
$2.08
收盘价：Jan 16, 16:00:00 GMT-5
$12.91
-12.59%
$-1.85
盘后：Jan 16, 20:00:00 GMT-5
关键数据
前收盘价
$12.69
开盘价
$12.3
当日区间
$11.91 - $18.4
52周范围
$0.46 - $19.95
交易量
2.7M
平均成交量
1.2M
每股收益（TTM）
-6.62
股息收益率
--
市值
$1.6B
什么是 NBY？
NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. The company is headquartered in Emeryville, California and currently employs 14 full-time employees. The company went IPO on 2007-10-26. The firm manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.